Sales decline 69.62% to Rs 15.48 crore
Net Loss of Parenteral Drugs (India) reported to Rs 22.67 crore in the quarter ended June 2016 as against net loss of Rs 14.43 crore during the previous quarter ended June 2015. Sales declined 69.62% to Rs 15.48 crore in the quarter ended June 2016 as against Rs 50.95 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales15.4850.95 -70 OPM %-31.6510.36 -PBDT-22.58-9.11 -148 PBT-27.10-14.37 -89 NP-22.67-14.43 -57Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
